Welcome to our dedicated page for VACIWS news (Ticker: VACIWS), a resource for investors and traders seeking the latest updates and insights on VACIWS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect VACIWS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of VACIWS's position in the market.
Viking Acquisition Corp. I (NYSE: VACI.U) closed its initial public offering on November 3, 2025, raising $230 million through sale of 23,000,000 units at $10.00 per unit, including 3,000,000 units from the underwriters’ full over-allotment exercise.
Each unit contains one Class A ordinary share and one-third of one redeemable warrant; whole warrants are exercisable to buy one Class A share at $11.50 per share. Units began trading on the NYSE under VACI.U on October 31, 2025; separate trading of shares and warrants is expected under VACI and VACI WS. Cohen & Company Capital Markets acted as lead book-running manager.
Viking Acquisition Corp. I (NYSE: VACI.U) priced an initial public offering of 20,000,000 units at $10.00 per unit, representing aggregate gross proceeds of $200,000,000. Each unit contains one Class A ordinary share and one‑third of one redeemable warrant; whole warrants exercisable to buy one Class A share at $11.50 per share, subject to adjustment.
The units are expected to begin trading on the New York Stock Exchange under the ticker VACI.U on October 31, 2025; when separated, shares and warrants are expected to trade as VACI and VACI WS. Cohen & Company Capital Markets is sole book‑running manager. The underwriters have a 45‑day option to purchase up to 3,000,000 additional units. The offering is expected to close on November 3, 2025, subject to customary conditions and S‑1 effectiveness.
